Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
11.11
+0.31 (2.87%)
Jan 30, 2025, 4:00 PM EST - Market closed
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for EBS stock have an average target of 14.33, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 28.98% from the current stock price of 11.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EBS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +35.01% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +35.01% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +35.01% | Dec 30, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +8.01% | Nov 7, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +44.01% | Sep 13, 2024 |
Financial Forecast
Revenue This Year
1.12B
from 1.05B
Increased by 6.26%
Revenue Next Year
1.14B
from 1.12B
Increased by 2.42%
EPS This Year
-0.82
from -14.85
EPS Next Year
2.09
from -0.82
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2B | 1.2B | 1.0B | ||
| Avg | 1.1B | 1.1B | 998.9M | ||
| Low | 1.1B | 1.1B | 969.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.8% | 9.8% | -9.1% | ||
| Avg | 6.3% | 2.4% | -12.5% | ||
| Low | 1.4% | -3.8% | -15.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.66 | 2.17 | 1.60 |
| Avg | -0.82 | 2.09 | 1.54 |
| Low | -0.98 | 2.03 | 1.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | -23.7% |
| Avg | - | - | -26.6% |
| Low | - | - | -28.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.